Belite Bio chief medical officer Hendrik Peter Scholl reports $80,048.70 ADS disposal

BLTE•2026-10-05

Hendrik Peter Scholl sold 500 Belite Bio American depositary shares on Oct. 1, valued at $80,048.70.

1. Sale details

The sales were priced from $163.625 to $170.02 per share. Scholl’s indirect holding through Bioptima Ltd. fell to 14,500 shares; the transactions were made under a Rule 10b5-1 trading plan adopted June 25, 2026.

Sources

Belite Bio chief medical officer Hendrik Peter Scholl reports $80,048.70 ADS disposal

Sec

Belite Bio chief medical officer Hendrik Peter Scholl reports $80,048.70 ADS disposal

1. Sale details

Related News

CoinShares director Daniel Masters disposes of $494,746 in ordinary shares

IPG Photonics’ IPG Defense showcases CROSSBOW laser systems at Land Forces 2026

Nasdaq halts trading in ITOC pending news at 7:50 p.m.

Sources

Belite Bio chief medical officer Hendrik Peter Scholl reports $80,048.70 ADS disposal

Skyworks says Qorvo noteholders tender 92% in exchange offers for 2029, 2031 senior notes

Carriage Services terminates equity distribution agreement on October 4, 2026